Literature DB >> 6811508

Immunohistochemical distribution of aldose reductase.

T S Kern, R L Engerman.   

Abstract

Aldose reductase (AR) has been purified from canine kidneys, and a monospecific antibody against the enzyme prepared. These antibodies were used in an immunohistochemical test to detect tissue sites of aldose reductase in the dog, a species known to develop diabetic lesions morphologically identical to those seen in diabetic patients. Using this method, the enzyme has been demonstrated in numerous cell types, including lens epithelium, aortic endothelium and smooth muscle, Schwann cells of peripheral nerves, and, in the kidney, interstitial cells and cells of Henle's loop and the collecting tubules. Many other cells and tissues, including capillaries throughout the body, lack immunoreactive aldose reductase. The distribution of the immunoreactive enzyme is compatible with a potential role of the enzyme in the aetiology of some complications of diabetes, namely cataract, neuropathy, macroangiopathy and renal papillary necrosis, but not the microvascular complications.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6811508     DOI: 10.1007/bf01011860

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  19 in total

1.  Determination of serum proteins by means of the biuret reaction.

Authors:  A G GORNALL; C J BARDAWILL; M M DAVID
Journal:  J Biol Chem       Date:  1949-02       Impact factor: 5.157

Review 2.  Alterations in the composition and metabolism of the inner aortic wall associated with increased polyol pathway activity.

Authors:  A I Winegrad; A D Morrison; R S Clements
Journal:  Horm Metab Res       Date:  1974       Impact factor: 2.936

3.  Inhibition of erythrocyte pseudoperoxidase activity by treatment with hydrogen peroxide following methanol.

Authors:  J G Streefkerk
Journal:  J Histochem Cytochem       Date:  1972-10       Impact factor: 2.479

Review 4.  Mechanisms initiating cataract formation. Proctor Lecture.

Authors:  J H Kinoshita
Journal:  Invest Ophthalmol       Date:  1974-10

5.  Microangiopathy in the experimentally diabetic animal.

Authors:  J M Bloodworth; R L Engerman; P J Anderson
Journal:  Adv Metab Disord       Date:  1973

6.  Animal models of diabetic retinopathy.

Authors:  R L Engerman
Journal:  Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol       Date:  1976 Jul-Aug

7.  Distribution of aldose reductase in ocular tissues.

Authors:  T S Kern; R L Engerman
Journal:  Exp Eye Res       Date:  1981-08       Impact factor: 3.467

Review 8.  Hyperglycemia, polyol metabolism, and complications of diabetes mellitus.

Authors:  K H Gabbay
Journal:  Annu Rev Med       Date:  1975       Impact factor: 13.739

9.  Immunohistochemical localization of aldose reductase. II. Rat eye and kidney.

Authors:  M A Ludvigson; R L Sorenson
Journal:  Diabetes       Date:  1980-06       Impact factor: 9.461

10.  Immunohistochemical localization of aldose reductase. I. Enzyme purification and antibody preparation--localization in peripheral nerve, artery, and testis.

Authors:  M A Ludvigson; R L Sorenson
Journal:  Diabetes       Date:  1980-06       Impact factor: 9.461

View more
  10 in total

Review 1.  Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Authors:  T Baba; S Neugebauer; T Watanabe
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

2.  Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis.

Authors:  H L Rittner; V Hafner; P A Klimiuk; L I Szweda; J J Goronzy; C M Weyand
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

Review 3.  Bioenergetics in diabetic neuropathy: what we need to know.

Authors:  Lucy M Hinder; Andrea M Vincent; Charles F Burant; Subramaniam Pennathur; Eva L Feldman
Journal:  J Peripher Nerv Syst       Date:  2012-05       Impact factor: 3.494

4.  Vasoreactivity and prostacyclin release in streptozotocin-diabetic rats: effects of insulin or aldose reductase inhibition.

Authors:  E J Stevens; G B Willars; P Lidbury; F House; D R Tomlinson
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

5.  Fine-structural localization of aldose reductase and ouabain-sensitive, K(+)-dependent p-nitro-phenylphosphatase in rat peripheral nerve.

Authors:  H C Powell; R S Garrett; P F Kador; A P Mizisin
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

6.  Loss of Glyoxalase 1 Induces Compensatory Mechanism to Achieve Dicarbonyl Detoxification in Mammalian Schwann Cells.

Authors:  Jakob Morgenstern; Thomas Fleming; Dagmar Schumacher; Volker Eckstein; Marc Freichel; Stephan Herzig; Peter Nawroth
Journal:  J Biol Chem       Date:  2016-12-12       Impact factor: 5.157

7.  Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes.

Authors:  Steven Daniel Funk; Arif Yurdagul; A Wayne Orr
Journal:  Int J Vasc Med       Date:  2012-02-14

Review 8.  Immortalized adult rodent Schwann cells as in vitro models to study diabetic neuropathy.

Authors:  Kazunori Sango; Hiroko Yanagisawa; Shizuka Takaku; Emiko Kawakami; Kazuhiko Watabe
Journal:  Exp Diabetes Res       Date:  2011-06-13

9.  Effect of intravitreal injection of ranibizumab on retinal ganglion cells and microvessels in the early stage of diabetic retinopathy in rats with streptozotocin-induced diabetes.

Authors:  Ang Xiao; Qiong Zhou; Yi Shao; Hui-Feng Zhong
Journal:  Exp Ther Med       Date:  2017-05-05       Impact factor: 2.447

10.  Effects of long-term treatment with ranirestat, a potent aldose reductase inhibitor, on diabetic cataract and neuropathy in spontaneously diabetic torii rats.

Authors:  Ayumi Ota; Akihiro Kakehashi; Fumihiko Toyoda; Nozomi Kinoshita; Machiko Shinmura; Hiroko Takano; Hiroto Obata; Takafumi Matsumoto; Junichi Tsuji; Yoh Dobashi; Wilfred Y Fujimoto; Masanobu Kawakami; Yasunori Kanazawa
Journal:  J Diabetes Res       Date:  2013-03-13       Impact factor: 4.011

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.